Page last updated: 2024-10-23

astemizole and Basophilic Leukemia, Acute

astemizole has been researched along with Basophilic Leukemia, Acute in 2 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischer, MJ2
Paulussen, JJ2
Horbach, DA1
Roelofsen, EP1
van Miltenburg, JC1
de Mol, NJ2
Janssen, LH2

Other Studies

2 other studies available for astemizole and Basophilic Leukemia, Acute

ArticleYear
Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antigens; Astemizole; beta-N-Acetylhexosaminidases; Cal

1995
Dual effect of the anti-allergic astemizole on Ca2+ fluxes in rat basophilic leukemia (RBL-2H3) cells: release of Ca2+ from intracellular stores and inhibition of Ca2+ release-activated Ca2+ influx.
    Biochemical pharmacology, 1998, Apr-15, Volume: 55, Issue:8

    Topics: Animals; Anti-Allergic Agents; Astemizole; Barium; Calcium; Calcium Channels; Exocytosis; Leukemia,

1998